Sunday 11 October 2026 Export all BMY data to Excel Powerpack

Bristol Myers Squibb Company

BMY Healthcare Drug Manufacturers General

Bristol Myers Squibb Company’s revenue for fiscal 2025 (year ended December 2025) was $48.2 billion, roughly unchanged from fiscal 2024. In the quarter to June 2026, revenue grew 5.74%, EPS grew 153.1%, free cash flow fell 13.2% and total debt fell 12.3%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years.

59.12 0.46 −0.77%
Market cap
$121.7B
P/E
13.0×
Fwd P/E
11.2×
Dividend yield
4.26%
F-score
8/9
Altman Z
2.14
Beneish M
−2.69
Dividend safety
63/100

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Total current assets
29,390.00 29,780.00 31,770.00 27,273.00 33,262.00 30,192.00 29,354.00 17,716.00 14,854.00 13,704.00
Total non-current assets
60,648.00 62,823.00 63,389.00 69,547.00 76,052.00 88,289.00 100,590.00 17,270.00 18,697.00 20,003.00
Total Assets
90,038.00 92,603.00 95,159.00 96,820.00 109,314.00 118,481.00 129,944.00 34,986.00 33,551.00 33,707.00
Total current liabilities
23,417.00 23,774.00 22,262.00 21,890.00 21,868.00 19,080.00 18,304.00 10,654.00 9,563.00 8,841.00
Total non-current liabilities
48,115.00 52,441.00 43,412.00 43,812.00 51,440.00 61,519.00 59,942.00 10,205.00 12,141.00 8,519.00
Total liabilities
71,532.00 76,215.00 65,674.00 65,702.00 73,308.00 80,599.00 78,246.00 20,859.00 21,704.00 17,360.00
Common Equity (Total)
18,506.00 16,388.00 29,485.00 31,118.00 36,006.00 37,882.00 51,698.00 14,127.00 11,847.00 16,347.00
Shareholders Equity (Total)
18,506.00 16,388.00 29,485.00 31,118.00 36,006.00 37,882.00 51,698.00 14,127.00 11,847.00 16,347.00
Total Debt
45,111.00 49,649.00 39,772.00 39,320.00 44,553.00 50,676.00 46,733.00 7,349.00 7,962.00 6,708.00

Show all line items

In millions of $ except per-share values · columns are period end dates